Cleerly LABS vs Libby Echo:Prio
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely detect, quantify, and characterize atherosclerosis and stenosis. This tool is ideal for clinicians focused on personalized heart disease management, including tracking disease progression over time and detailed plaque assessment.
View Cleerly LABS →Choose Libby Echo:Prio if…
Choose Libby Echo:Prio if you require fast, consistent, and automated cardiac measurements from echocardiograms to support clinical decision-making. This cloud-based platform is best suited for scenarios where remote access, high-volume analysis, and standardized quantification of cardiac function are critical.
View Libby Echo:Prio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Libby Echo:Prio |
|---|---|---|
| Pricing | Per analysis | Custom |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Cloud-based |
| BAA Available | Yes AI-estimated | No AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | No AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS is a web-based software with features like 3D visualization of coronary arteries and integration with PACS, RIS, and EHR via Cleerly Proxy. While Libby Echo:Prio is also cloud-based and integrates into workflows, Cleerly's emphasis on comprehensive 3D visualization for complex CCTA data offers a potentially richer and more intuitive user experience for detailed cardiac imaging analysis.
Clinical Value
Cleerly LABSCleerly LABS offers comprehensive analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management and tracking disease progression over time. Libby Echo:Prio provides fast, data-driven echocardiogram analysis for automated cardiac measurements and decision support. While both are FDA-cleared and valuable, Tool A's broader scope in characterizing plaque and tracking disease progression for heart attack prevention presents a more comprehensive and proactive clinical impact.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing details, including a retail price and a discounted offer, along with information on potential insurance coverage and out-of-pocket costs. In contrast, Libby Echo:Prio's pricing is listed as 'custom' with a directive to 'contact vendor for details'. This lack of transparency for Tool B makes it impossible to assess its value proposition without direct engagement, giving Tool A a clear advantage in pricing clarity.
Enterprise Readiness
Cleerly LABSCleerly LABS explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, along with cloud-based deployment on AWS and integration capabilities with PACS, RIS, and EHR. Libby Echo:Prio, while FDA-cleared and cloud-based, explicitly states 'no' for both BAA and HIPAA compliance. This critical difference makes Tool A significantly more prepared for enterprise adoption in healthcare settings.
Innovation
Cleerly LABSCleerly LABS aims to 'create a new standard of care to eliminate heart attacks' through AI-powered CCTA for comprehensive plaque assessment and tracking disease progression. Libby Echo:Prio focuses on fast, data-driven echocardiogram analysis for automated measurements and decision support. While both utilize AI for cardiac imaging, Tool A's ambition to redefine preventative care through detailed plaque characterization and longitudinal tracking demonstrates a higher degree of innovation.
Support & Docs
Cleerly LABSCleerly LABS provides clear channels for client support, including a dedicated form for technical support and specified operating hours (Monday-Friday, 10 am ET to 6 pm ET). It also offers resources like billing guidelines and integration support from a 'Solution Architect team'. Dyad Medical's website for Libby Echo:Prio offers a general contact form and email for inquiries, but lacks specific details on dedicated technical support, user documentation, or a knowledge base for its medical AI product.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Libby Echo:Prio |
|---|---|---|
| Name | Cleerly LABS | Libby Echo:Prio |
| Company | Cleerly | Dyad Medical |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared, cloud-based AI platform for fast, data-driven echocardiogram analysis, providing decision support and automated cardiac measurements for clinicians. |
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | Echocardiogram |
| Key Features (Selected) | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module) | AI-powered cardiac image analysis, Fast, data-driven echocardiogram image analysis, Decision-making support for cardiac function quantification, Automated estimation of cardiac measurements |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Libby Echo:Prio.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Libby Echo:Prio
Backers
Who funded each tool's parent company.